[Clinical and radiological effectiveness of natalizumab extended dosage interval in patients with relapsing multiple sclerosis]. [PDF]
García-Estévez DA +4 more
europepmc +1 more source
IntroductionThere are no reports in LATAM related to longitudinal humoral and cellular response to adenovirus based COVID-19 vaccines in people with Multiple Sclerosis (pwMS) under different disease modifying therapies (DMTs) and neutralization of the ...
Berenice Anabel Silva +38 more
doaj +1 more source
[Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report]. [PDF]
Lafuente-Gómez G +11 more
europepmc +1 more source
Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2
G. Álvarez Bravo, L. Ramió i Torrentà
doaj +1 more source
Background: According to the literature, patients with multiple sclerosis (MS) are less active and show higher levels of sedentary behaviour than the general population of the same age range. This study aims to explore the impact of the COVID-19 pandemic
C. Santoyo-Medina +12 more
doaj +1 more source
SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis. [PDF]
Piñar Morales R +2 more
europepmc +1 more source
Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America. [PDF]
Rojas JI +15 more
europepmc +1 more source
Age, motor dysfunction and neuropsychiatric symptoms impact quality of life in multiple sclerosis. [PDF]
Brandão PMF +5 more
europepmc +1 more source
Content, educational value and quality analysis of videos about neurorehabilitation in people with multiple sclerosis on YouTube®. [PDF]
Cano-de-la-Cuerda R +8 more
europepmc +1 more source

